Calcitonin Gene-Related Peptide Receptor Antagonists
- Calcitonin Gene-Related Peptide Receptor Antagonists
- Accession Number
Pharmacologic agents that block NOCICEPTIVE PAIN signaling from CALCITONIN GENE-RELATED PEPTIDE RECEPTORS. They may be useful for the treatment of pain associated with MIGRAINE DISORDERS and OSTEOARTHRITIS.
Drug Drug Description Erenumab A calcitonin-gene related peptide antagonist used to prevent migraines. Galcanezumab A calcitonin-gene related peptide antagonist used to prevent migraines and treat cluster headaches. Rimegepant An oral CGRP receptor antagonist used for the acute treatment of migraines with or without aura in adults. Ubrogepant An oral CGRP antagonist used in the acute treatment of migraine with or without aura. Fremanezumab A humanized monoclonal antibody directed against human calcitonin-gene related peptide to prevent migraines. Olcegepant For the treatment of migraine headaches. Atogepant An oral CGRP antagonist used for the preventative therapy of episodic migraine headaches. Zavegepant A calcitonin gene-related peptide receptor antagonist indicated for the acute treatment of migraine with or without aura.
- Drugs & Drug Targets